Structure Therapeutics Inc (GPCR) Quality Analysis

GPCR GoodMoat Verdict

Full signal breakdown coming soon. Use the X-Ray tool for a detailed analysis.

Run Stock X-Ray →

GPCR Profitability

Profitability trend analysis coming soon

GPCR Growth

Growth trend analysis coming soon

GPCR Financial Health

Financial health indicators coming soon

GPCR Quality & Fundamental Analysis

Structure Therapeutics Inc (GPCR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ. This quality analysis page evaluates Structure Therapeutics Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.

Structure Therapeutics Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. and a return on equity (ROE) of -11.23%. Return on assets (ROA) stands at -10.75%.

The debt-to-equity ratio is 0.00, with a current ratio of 24.81.

GoodMoat's quality analysis uses AI-powered insights to evaluate whether Structure Therapeutics Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.